The present study aimed to evaluate PIK3R1 status in ovarian carcinomas by analyzing mutations, copy number alterations, and mRNA expression, in the context of the clinicopathological features of these tumors. This evidence concerns the gene PIK3R1 and ovarian carcinoma.